Neutralizing antibodies to nucleoside diphosphate kinase inhibit the enzyme in vitro and in vivo: evidence for two distinct mechanisms of activation of atrial currents by ATPγS  by Yi, Xiao B. et al.
ELSEVIER Biochimica et Biophysica Acta 13 l 0 (1996) 334-342 
Biochi ~mi  
et Biophysica A~ta 
Neutralizing antibodies to nucleoside diphosphate kinase inhibit the 
enzyme in vitro and in vivo: evidence for two distinct mechanisms of 
activation of atrial currents by ATPT S 
Xiao B. Yi, Nicole M. Sweitzer, Angela de S. Otero * 
Department ofMolecular Physiology and Biological Physics, University of Virginia Medical School, Charlottesville, VA 22908, USA 
Received 6June 1995; accepted 12 September 1995 
Abstract 
Nucleoside diphosphate kinase (NDPK) participates in multiple cellular functions, yet the molecular mechanisms of its involvement 
are often unknown, given that there are no specific inhibitors for the enzyme from vertebrates. We developed antibodies against NDPK by 
immunization of rabbits with the enzyme from bullfrog skeletal muscle. The antibodies pecifically recognized the enzyme from frog 
tissues, and cross-reacted with NDPK from Xenopus. In contrast to mammalian NDPK, the amphibian enzyme licited antibodies that 
inhibit potently its catalytic function. We utilized the inhibitory properties of these immunoglobulins to examine the role of NDPK on the 
ATP,/S-induced stimulation of Ca e ÷ and K ÷ currents of cardiac myocytes. Injection of NDPK-neutralizing Fab fragments into atrial cells 
reduced considerably the effect of ATPTS on muscarinic K + currents, but not on Ca 2÷ currents. Therefore, ATP3,S increases calcium 
and potassium currents of atrial cells by two distinct mechanisms. NDPK is essential for the conversion of ATP3,S into GTPTS which 
leads to muscarinic K ÷ channel activation but not for the stimulation of Ca 2 ÷ currents by ATPTS. The results demonstrate that antibodies 
to frog NDPK block the activity of the enzyme in vivo and in vitro, and can be used to determine the relevance of NDPK and its catalytic 
activity to the function of vertebrate cells. 
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1. Introduction 
In recent years, the role of nucleoside diphosphate 
kinase (NDPK1; E.C. 2.7.4.6) in cells has been shown to 
transcend the rephosphorylation of nucleoside diphos- 
phates at the expense of ATP. The growing list of cellular 
processes in which NDPK has been implicated includes 
G-protein-mediated transmembrane signalling (reviewed in 
refs. [1-3]), transcriptional control [4,5], development at 
[6,7] and tumor progression and metastasis [6-10]. The 
involvement of NDPK in some of these events is not 
invariably a result of its phosphotransferase activity; for 
Abbreviations: NDPK, nucleoside diphosphate kinase; SDS-PAGE, 
sodium dodecylsulfate polyacrylamide gel electrophoresis; ATPTS, 
adenosine (3,-thio)-triphosphate; GTP'/S, guanosine (3,-thio)-triphosphate; 
HRP, horseradish peroxidase; DTT, dithiothreitol; PMSF, phenylmethyl- 
sulfonyl fluoride; IKAch, muscarinic K + currents; Ica, calcium currents. 
* Corresponding author. Fax: + 1 (804) 982-1616; e-mail: 
ado2t @ virginia.edu. 
0167-4889/96/$15.00 © 1996 Elsevier Science B.V. All rights reserved 
SSDI 0167-4889(95)00164-6 
instance, a mutant enzyme that is catalytically inactive still 
acts as a transcription factor for the c-myc gene in vitro [5]. 
In intact cells, it is not trivial to establish a relationship 
between the participation of NDPK in a given system and 
its ability to transfer phosphate, given that there are no 
known specific inhibitors for this enzyme. High concentra- 
tions of UDP are frequently used to block NDPK in 
broken cell preparations [11-13]. However, in cells this 
nucleotide interacts specifically with other proteins (e.g., 
glycogen synthethase [14] and ATP-sensitive K ÷ channels 
[15]), and therefore has the potential to elicit physiological 
changes unrelated to its effects on NDPK. A number of 
experimental manipulations have been utilized to interfere 
specifically with the function of NDPK in vivo. Some of 
these, e.g., gene overexpression, gene inactivation, block 
of expression by antisense oligonucleotides [16-18], 
change the overall levels of the target protein, but do not 
address the question of the contribution of catalytic activ- 
ity to function. Another approach is to use specific anti- 
bodies to reduce or eliminate nzyme activity in situ. Note, 
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however, that as a rule antibodies raised against NDPK do 
not inhibit the enzyme at all [19,20] or are weakly in- 
hibitory [21]. The exception is found with rabbit antibodies 
to Dictyostelium NDPK which are strong blockers of 
enzyme activity [22-24], and were recently used to 
demonstrate hat Dictyostelium NDPK participates in sig- 
nalling through cAMP receptors and G-proteins [24]. Un- 
fortunately, polyclonal anti-Dictyostelium NDPK antibod- 
ies are highly species-specific: neither frog nor beef NDPK 
activities are blocked by these antisera (A.S. Otero, unpub- 
lished data) and the cross-reactivity with the human en- 
zyme is very poor (M.L. Lacombe, personal communica- 
tion). Thus, the scope of antibodies to Dictyostelium ap- 
pears to be limited to the study of NDPK function in 
cellular slime mold. 
The objective of the present work was to generate 
neutralizing antibodies to NDPK, in order to evaluate its 
role and mechanism of action in intact cells. When anti- 
bodies are used in an environment of this complexity, the 
main caveat lies in the purity of the antigen utilized. To 
this end, we developed a procedure for the purification of 
NDPK to apparent homogeneity, atyields compatible with 
antibody production. Bullfrogs (Rana catesbeiana) were 
chosen as an NDPK source to maximize the likelihood of 
production of high affinity, neutralizing antibodies in rab- 
bits. Although this enzyme is conserved throughout evolu- 
tion [6,8-10,25-28], we expected that the evolutionary 
distance between amphibian and mammals would be suffi- 
cient to allow the production of blocking antibodies. As 
shown below, the polyclonal antisera obtained o recog- 
nize and inhibit amphibian NDPK with high affinity in 
atrial myocytes and in cell--free preparations. Additionally, 
the antibodies react with the enzyme from Xenopus 
oocytes, and may help define the physiological functions 
of NDPK not only in adult vertebrate cells, but also in the 
processes that take place during maturation and early 
development. 
2. Materials and methods 
The dye ligand test kit (RDL9) and Reactive Yellow 3 
agarose were from Sigma.. HRP-labeled anti-rabbit IgG, 
lactate dehydrogenase, pyruvate kinase and ATPTS were 
from Boehringer Mannheim. EconoPac cartridges (5 ml) 
were from BioRad. [35S]ATPTS (1000 Ci/mmol) was 
from Amersham. [a- 32 P]GTP (3000 Ci/mmol) was from 
DuPont NEN. All other chemicals used were of the highest 
purity. Human recombinant NDPK A, antiserum to D. 
discoideum NDPK and affinity-purified antibodies to hu- 
man erythrocyte NDPK A were a generous gift from Drs. 
Marie-Lise Lacombe (INSERM, Facult6 de Medecine 
Saint-Antoine, Paris) and loan Lascu (Universit6 de Bor- 
deaux). Fab fragments from polyclonal antibodies raised in 
rabbits to B. pertussis adenylate cyclase toxin were a gift 
from E.L. Hewlett (University of Virginia) 
2.1. Methods 
2.1.1. Enzyme purification and preparation of subcellular 
fractions 
NDPK was purified by fractionation with ammonium 
sulfate, dye affinity chromatography and ion exchange 
chromatography. We evaluated various agarose-linked dyes 
for their selectivity towards NDPK. Cibachron Blue 3GA, 
Reactive Green 19, Reactive Red 120 and Reactive Yellow 
3 retain over 90% of the NDPK in muscle extracts and 
release virtually all bound enzyme in the presence of ATP. 
However, the yellow dye matrix adsorbs the least amounts 
(16%) of total protein in a frog muscle extract, and was 
therefore selected for our protocol. 
All manipulations were carried out at 4°C. NDPK was 
purified from 200 g of leg skeletal muscle tissue obtained 
from adult bullfrogs. The tissue was homogenized in 500 
ml of MED buffer (MOPS. Na 25 mM, EDTA 1 mM, 
DTT 1 mM, PMSF 0.25 mM, benzamidine 0.1 mM, pH 
7.5) with a Waring blender and centrifuged at 14000 × g 
for 20 min. The supernatant was recentrifuged for 60 min 
at 186000 × g, and the clarified extract was fractionated 
with ammonium sulfate; NDPK precipitated between 45 
and 85% saturation. The precipitate was dialyzed against 
MED, centrifuged at 48 000 × g for 30 min and loaded, at 
a flow rate of 2 ml/min, onto a column (2.5 × 17.5 cm) of 
Reactive Yellow 3 agarose equilibrated with MED. The 
column was washed with MEDN buffer (MED with 0.15 
M NaC1 added) until the A280 returned to the baseline 
value, and NDPK was eluted with 0.5 mM Na2ATP in 
MEDN. Elution of protein was followed at 290 nm [29]. 
Fractions of 9 ml were collected; those with high specific 
activity were pooled, concentrated in a Centriprep 30 and 
incubated with 1 mM ADP and 2 mM MgC12 for 20 min 
on ice in order to reduce the amount of phosphoenzyme 
formed during ATP elution from the dye absorbent. Phos- 
phorylation can induce marked changes in the isoeletric 
point of NDPK [30-32] and may intensify its heteroge- 
neous behavior during subsequent ion exchange chro- 
matography steps [28,33]. The sample was dialysed 
overnight against TMED (Tris 10 raM, EDTA 1 mM, DTT 
1 mM, benzamidine 0.1 mM, adjusted to pH 7.2 with 
MOPS). and applied to two ion exchange cartridges, 
Econopac Q and CM, connected irectly in series, equili- 
brated in TMED. The cartridges were washed with TMED 
buffer and eluted with a linear gradient of 0-0.5 M NaC1 
at 2 ml/min. The bulk of the enzyme activity, found in the 
flow-through fraction, was pooled, concentrated and ap- 
plied to an Econopac S cartridge. The sample was eluted 
using the protocol described above for the Q-CM columns; 
fractions were collected in tubes containing 3 /zl of 1 M 
MgC12. All the NDPK activity passed through the column; 
active fractions were concentrated and stored in liquid 
nitrogen. 
Frog cardiac sarcolemma was isolated as described [34]. 
Bovine sarcolemma was purified from beef atria by the 
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procedure of Jones [35]. To obtain homogenates and cy- 
tosol from frog heart, the tissue was homogenized in 5 
volumes of buffer A (0.1 M PIPES • Na, pH 7.5, with 1 
mM PMSF and 10/zg/ml each of leupeptin, aprotinin and 
pepstatin) in a mini Waring blender for 15 s on the low 
setting, followed by 10 passes in a teflon-glass homoge- 
nizer. The suspension was centrifuged for 2 min at 200 X g, 
and the supernatant was re-homogenized as above. After 
centrifugation at 1500 X g, the pellet was discarded and 
cytosolic fractions were obtained by spinning the super- 
natant (crude homogenate) in a Beckman Airfuge at 30 psi 
for 30 rain. Xenopus oocyte extracts were prepared by 
homogenization f oocytes in buffer A, followed by cen- 
trifugation for 2 min at 16 000 X g. The top and bottom 
layers were discarded, while the middle layer was divided 
in aliquots and stored at -20°C. 
2.2. Enzyme and protein assays 
Enzyme activity measurements were performed in du- 
plicate or triplicate. Results reported as the mean (___ S.E.) 
are the average of at least three experiments. NDPK 
activity was determined at 22°C by the coupled assay 
procedure as described by Lascu et al. [36], with dTDP 
instead of 8-Br-IDP; the oxidation of NADH was followed 
at 340 nm. One unit (U) of NDPK is defined as the amount 
of enzyme that transfers 1 /zmol of phosphate from ATP 
to dTDP per minute. Fractions to be assayed or antibodies 
were diluted in 75 mM KC1, 5 mM MgC12, 1 mg/ml BSA 
and 50 mM Tris. HC1 (pH 7.5) (assay buffer). The reac- 
tion volume was 0.7 ml, with ATP as phosphate donor at 1 
mM. In standard assays the concentration f dTDP was 0.4 
mM, while 0.14 mM was used for assaying column frac- 
tions. Kinetic parameters were determined with ATP in the 
range of 0.05-1 mM with dTDP fixed at 0.2 mM, and also 
with dTDP varying from 0.02 to 0.4 mM with ATP held at 
0.5 mM. Purified enzyme or subcellular fractions were 
incubated with serum, purified IgG or Fab fragments in 
assay buffer, in a final volume of 50/~1. Blanks containing 
no enzyme were assayed in parallel. Adenylate kinase 
activity was measured under the same conditions, with 1 
mM AMP instead of dTDP; samples were incubated in 
assay buffer with 1 mM DTT for 30 min prior to assays to 
optimize enzyme activity. The protein concentration was 
measured by the bicinchoninic acid assay (Pierce) with 
BSA or IgG as the standard. 
2.3. Electrophoretic methods 
Samples were mixed with an equal volume of 2X 
electrophoresis ample buffer (8 M urea, 4.6% SDS, 10% 
/3-mercaptoethanol and 125 mM Tris. HC1, pH 6.8) and 
dispersed in a high power ultrasonic bath (Laboratory 
Supplies) for 10 min. Proteins were resolved by SDS-poly- 
acrylamide gel electrophoresis (SDS-PAGE) [37] in mini 
14% (0.75 mm thick) or 4-20% (1 mm thick) gels, and 
detected with Coomassie Blue R-250 followed by silver 
staining [38]. Denaturing isoelectric focusing was per- 
formed in 5% slab gels (0.75 mm thick), with 2.4% 
ampholytes (pH range 3.5-10) [38]. 
2.4. Immunological methods 
Development of specific antisera. A pool of purified 
NDPK obtained from three preparations using the proce- 
dure described above was used to raise rabbit anti-frog 
NDPK antibodies. Antibodies were prepared by Berkeley 
Antibody Company (BABCO, Richmond, CA). Three New 
Zealand White rabbits were injected subcutaneously (peri- 
lymphonodal region) with 330 /zg antigen emulsified in 
Freund's complete adjuvant. The immune response was 
boosted by intramuscular injection with 0.17/xg of antigen 
in Freund's incomplete adjuvant every 3 weeks, and the 
rabbits were bled 10 days later. ELISA assays were per- 
formed by the Lymphocyte Culture Center of the Univer- 
sity of Virginia. 
Purification of IgG fractions and preparation of Fab 
fragments. IgG was purified from serum on protein A 
columns (Pierce, BioRad). Fab fragments were obtained by 
digestion of purified IgG with immobilized papain fol- 
lowed by chromatography in protein A using the procedure 
recommended by the manufacturer (Pierce). 
Immunoblotting. Proteins were transferred to Immo- 
bilon-P (Millipore) or nitrocellulose (0.1 /xm, Schleicher 
and Schuell) using a wet transfer unit (BioRad), in buffer 
containing 25 mM Tris, 190 mM glycine, 20% methanol 
and 0.025% SDS. Membranes were rinsed with PBS, 
blocked with 5% BSA in PBS for 2 h at room temperature 
and incubated for 2 h with primary antibodies diluted in 
blocking solution. After incubation with HRP-labeled 
anti-rabbit IgG (1:10,000) for 1 h, the bound antibodies 
were visualized with a chemiluminescence system 
(Amersham or DuPont NEN). 
2.5. Electrophysiological methods 
Bullfrog atrial cell dissociation, electrophysiological 
recordings and data analysis were performed as previously 
described [39]. The standard internal solution contained 80 
mM K-aspartate, 30 mM KC1, 1.0 mM EGTA, 2.5 mM 
Mg • ATP, 0.2 mM Li 4 . GTP, 5 mM Hepes • K (pH 7.4), 
while the external solution contained 90 mM NaC1, 2.5 
mM KC1, 5 mM MgC1 z, 2.5 mM CaC12 , 20 mM Hepes • Na 
(pH 7.4), 5/zM tetrodotoxin toblock Na + channels, and 1 
/zM acetylcholine (ACh) when indicated. The cell was 
held for 0.25 s at -85  mV between pulses of 0.25 s to 
-135, -90  and -5  mV. The test solution was internal 
solution with 2 mM ATPyS as the sole nucleotide and 2 
mM MgC12; when indicated, it contained Fab fragments at 
a concentration of 1.2 /xM. Prior to use, Fab fragments 
were suspended in internal solution by dialysis or gel 
filtration. A pressure-driven intracellular perfusion device 
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[40] was utilized to exchange the standard internal solution 
at the tip of the patch pipette for the test solution. The 
effect of anti-NDPK Fab on activation of calcium currents 
was determined in the same manner. Calcium currents 
(Ica) were measured as described by Otero et al. [41], in 
the solutions above and also in solutions where K + was 
substituted by Cs ÷, to control for a possible interference of 
muscarinic K + currents on the measurement of Ica. The 
increase caused by injection of ATPTS (mean + S.E.) was 
2.52 +__ 0.70-fold in K ÷ solutions (n = 5), and 2.09 _ 0.36- 
fold in Cs ÷ solutions (n = 4). In the presence of Fab 
fragments, Ica was stimulated 2.31 + 0.75-fold in K ÷ solu- 
tions (n = 7), and 3.17 __+ 1.59-fold in Cs ÷ solutions (n = 
3). There was no significant difference between the two 
sets of results. 
3. Results 
3.1. Purification and characterization of NDPK 
Results from one preparation obtained by the purifica- 
tion protocol described in Section 2 are shown in Table 1. 
In SDS-PAGE, purified frog NDPK migrates as a single 
band, with mobility corresponding to 18 kDa (Fig. 1A); 
this protein is specifically :recognized by affinity-purified 
antibodies to human NDPK A (not shown). In denaturing 
isoelectric focusing gels, the pI of this polypeptide is 6.3 
(Fig. 1B), which is close to the value reported for the 
acidic isoform of the mammalian enzyme [28,32,42]. Frog 
NDPK is eluted from Sephacryl HR200 in a single sym- 
metrical peak (Fig. 1C), with an estimated molecular weight 
of 100 kDa. This value is consistent with a hexamer, a 
common feature of NDPK from eukaryotes 
[8,22,28,30,31,43]. In contrast, 32p-labeled, partially puri- 
fied NDPK from Xenopus oocytes was eluted from a size 
exclusion column in multiple peaks over a broad region 
[44]. The difference may be due to the presence of other 
proteins in the Xenopus preparation, as well as to the 
experimental protocol employed. 
Preparations of frog NDPK have specific activities of 
2500-3200 U/mg (Table 1), with recoveries of 22-27% 
of the initial activity. The Kmap p for ATP, measured in 
the presence of 0.2 mM dTDP, is 0.15 raM, while the 
Kmap p for dTDP at 0.5 mM ATP is 0.19 mM; these values 
are comparable to those ohtained with NDPK from other 
sources [33]. The purified enzyme contains no detectable 
adenylate kinase. Also, a [a-32p]GTP overlay assay [45] 
of NDPK preparations shows no contamination by small G 
proteins. 
3.2. Characterization of antibodies to NDPK 
Immunization of rabbits with frog NDPK produced 
antisera with remarkably high levels of specific antibodies. 
For the first bleed, titers (half maximal response in ELISA) 
were 7.25 • 105, 1.1 • 105 and 1.8 • 105; subsequent boosts 
increases these values at most by a factor of 2. The serum 
with the highest titer was used in the experiments de- 
scribed below. 
In immunoblots the antiserum gave a strong signal with 
the purified enzyme at dilutions as low as 1:25,000; the 
pre-immune serum did not react at 1:300 (not shown). The 
immune serum recognized a band of 18 kDa in frog heart 
subcellular fractions (plasma membrane and cytosol) and 
Xenopus oocytes extracts. Weaker signals were obtained 
with mammalian (human and beef sarcolemmal) enzymes 
(Fig. 2). The immune serum also recognized native NDPK, 
immunoprecipitating the enzyme from bullfrog cardiac 
cytosol and sarcolemma, s well as from Xenopus oocyte 
extracts. Quantitative immunoprecipitation of frog cardiac 
cytosolic NDPK was observed at a dilution of 1:3000 (not 
shown). 
3.3. Inhibition of NDPK activity in vitro 
Purified skeletal muscle NDPK was half blocked at a 
serum dilution of 1:1450 (Fig. 3A); higher serum concen- 
trations resulted in the inhibition of about 80% of the 
activity. The activity of recombinant human NDPK A was 
not affected by the antibodies, indicating that the block is 
species-dependent. At a serum dilution of 1:300 the inhibi- 
tion of the enzyme proceeded with a biphasic time course 
(Fig. 3B). The block reached a maximum of 80% at 2.5 h; 
longer incubation times did not increase the extent of 
inhibition (not shown). Purified IgG gave similar results: 
although the IgG fraction inhibited 50% of the NDPK 
activity at 10 nM, at 375 nM the maximal block was 82%. 
The next group of experiments require that the antibod- 
ies block the reaction of NDPK with ATPyS. This was 
Table 1 
Purification of cytosolic NDPK from frog skeletal muscle 
Step Total protein Total activity Specific activity Yield Purification 
(mg) (/xmol/min) (p.mol/mg/min) (%) (-fold) 
Low speed supernatant 6350 7620 1.2 100 1 
High speed supernatant 5670 5940 1.0 78 0.8 
45-85% (NH4)2SO 4 4810 5230 1.1 69 0.9 
Reactive Yellow 3 agrose 2.4 4130 1721 54 1434 
Macro Q/CM 0.8 2210 2763 29 2303 
Macro S 0.65 1780 2738 23 2282 
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tested by incubating purified NDPK with pre-immune or 
with immune serum and then measuring formation of 
thiophosphorylated enzyme using [35S]ATPYS. At 25 /zM 
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Fig. 1. Characterization of purified NDPK by SDS-PAGE (A), isoelectric 
focusing (B) and gel filtration (C). A: Purified NDPK (0.6 /xg) was 
subjected to SDS-PAGE in a 4-20% gel. On the left are shown the 
positions and molecular weights of protein standards. The gel was stained 
initially with Coomassie blue and then silver-stained. B: Isoelectric 
focusing profile of NDPK (0.6 /zg) in a pH 3.5-10 gel; the scale on the 
right indicates the pH. The gel was stained as in A. C: Gel filtration 
profile of NDPK. The enzyme was applied in a volume of 1 ml to a 
Hi-Prep 16/60 Sephacryl HR-200 column equilibrated and eluted with 
50 mM Tris (pH 7.5 with MOPS), 150 mM NaCI and 0.02% NaN 3 at a 
flow rate of 20 rnl/h. The elution volumes of the molecular weight 
standards u ed to calibrate the column are indicated by numbered arrows 
(1: fl-amylase, 200 kDa; 2: alcohol dehydrogenase, 150kDa; 3: BSA, 66 
kDa; 4: carbonic anhydrase, 29kDa; 5: cytochrome c, 12.4 kDa). 
[35S]ATPTS and 40 /~M MgC12, a maximal level of 
0.47 _+ 0.05 mol thiophosphate ((S)P) per mol of enzyme 
monomer was obtained (not shown). Incubation of the 
enzyme with pre-immune serum yielded a similar value, 
0.50 _+ 0.02 tool (S)P/mol enzyme (Fig. 4). In contrast, 
the anti-NDPK antibodies decreased the final extent of 
label incorporation to 0.18 + 0.01 mol (S)P/mol enzyme, 
a reduction of 64% (Fig. 4). Therefore, the antibodies 
inhibit effectively the autophosphorylation f NDPK by 
ATPyS. 
3.4. Inhibition o f  NDPK activity in atrial cells 
We have previously shown that atrial muscarinic K + 
currents (IKAch) can be activated by ATPyS in the total 
absence of muscarinic agonists [46]. We suggested then 
that the effect of ATPyS on IKAch is not direct, but rather 
the outcome of thiophosphate transfer from this ATP 
analog into endogenous GDP, forming GTPy S. Activation 
of the G protein that couples muscarinic receptors to atrial 
K + channels, Gk, would reflect intracellular formation of 
GTPyS by a phosphotransferase id ntified tentatively as 
NDPK [l,46]. Subsequent work from other laboratories 
supported this idea, but relied also on indirect evidence 
[47,48]. The ability of anti-frog NDPK to specifically 
inhibit the enzyme provided us with a tool to test this idea 
directly, using the patch clamp technique [49]. ATPyS was 
injected into atrial myocytes in the presence of anti-NDP 
kinase Fab fragments, and the rate of IKAc, activation was 
measured and compared to the rate observed with ATPy S 
alone. Fab fragments were utilized in these experiments 
instead of immunoglobulins, in order to accelerate the 
loading of the antibody into the myocytes via the patch 
pipette. The loading time constant depends trongly on the 
molecular weight of the diffusing substance [50], and is 
slow for IgGs (160 kDa). Therefore, the smaller (55 kDa) 
Fab fragments are expected to be more effective within the 
time frame of these experiments. Anti-NDPK Fab frag- 
ments retained the ability to inhibit the enzyme in vitro: 
half-maximal inhibition took place at 1 /~M Fab. For 
cardiac cytosolic NDPK a maximal block of 70% was 
observed at 5/~M Fab. In intact cell experiments he molar 
ratio of Fab to enzyme achieved is much higher than in 
enzyme assays, given the minute amounts of enzyme 
present in a single cell and the comparatively arge volume 
of the patch pipette. Thus, the Fab concentration utilized, 
1.2 /xM, should produce a maximal block of cellular 
NDPK. 
Fig. 5A illustrates the effect of co-injection of 2 mM 
ATPyS and anti-NDPK Fab fragments on the muscarinic 
K + currents of atrial myocytes. After a short application of 
ACh to test the muscarinic response, injection of ATPyS 
into the cell led to gradual activation of IK~c, in the 
absence of agonist. A few minutes later, ACh was applied 
again, eliciting a maximal response, which persisted upon 
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Fig. 2. Reactivity of antibodies to NDPK in immunoblots. A: Samples resolved by electrophoresis on a 14% gel were probed with anti-NDPK serum 
(1:3,000) as described in Section 2. Lane 1: frog cardiac sarcolemma, 20/xg; lane 2: beef atrial sarcolemma, 40 tzg; lane 3, frog heart cytosol, 30 ~g; lane 
4, human NDPK A, 0.65 /xg; larLe 5, purified frog NDPK, 0.5 ~g. B. Xenopus oocyte extract (7.5 /xg) subjected to electrophoresis in a 4-20% gel; 
anti-NDPK serum dilution was 1:6000. The positions of molecular weight standards are indicated. 
agonist removal. If agonist-independent ac ivation were 
due to endogenous NDPK activity, injection of inhibitory 
Fab fragments with ATPT S should decrease the amounts 
of GTPy S formed, and reduce the rate of agonist-indepen- 
dent activation of IKAch. Also, given the inability of the 
i 
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Serum di lut ion Incubat ion  t ime (h) 
Fig. 3. A: Concentration dependence and time course of NDPK inhibition 
by antiserum. Purified NDPK (3.3 /xg/ml) was incubated on ice with 
immune (O)  or pre-immune ( i )  serum at the dilutions indicated. 
Activity was assayed after 2.5 h and plotted as percent of the activity of 
enzyme incubated alone. The Marquardt-Levenberg al orithm was uti- 
lized for non-linear curve-fitting of the immune serum data to the logistic 
function (solid line), y = (Ema x -Ernin)/( l  +(F/F0.5)b] + Emi, with Ema x 
(98.9%) and Ernin (22.9%) being the asymptotic maximum and minimum 
values of NDPK activity as percent of the control, F05 the logarithm of 
the serum dilution at the inflection point ( -3 .16)  and b the slope 
parameter ( - 19.3). B: Enzyme was incubated as described above for the 
times shown, with sera diluted to 1:300. The data obtained with immune 
serum were fitted to the sum of two exponentials (solid line). The 
amplitudes (a) and rate constants (k) obtained from the fit are: a I = 
49.04%, k I = 0.49 min -1 , a 2 = 50.96%, k 2 = 0.006 min -1 . Symbols are 
as in panel A. 
antibodies to elicit a total block of cellular NDPK, injec- 
tion of Fab should not affect he amplitude of the currents 
elicited by ACh at the end of the experiment. The affinity 
of G k for GTP3tS is extremely high [51] and the small 
amounts of GTP-yS formed in the presence of Fab should 
still induce full activation of IKAch when agonist is applied. 
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Fig. 4. Effect of antibodies on NDPK autophosphorylation by ATP~S- 
NDPK (150 pmol) was mixed with 5/~l immune (0 )  or pre-immune ((3) 
serum, in 40 /xl of 40 mM Tris.HC1 (pH 7.5), 60 mM KCI, 4 mM 
MgCI 2, with 0.8 /zg/ml of pepstatin, leupeptin and aprotinin, incubated 
for 30 rain at room temperature and transferred to ice. The enzyme/serum 
mix (5 /xl) was diluted with 45 /xl of phosphorylation buffer (final 
composition: 55 mM Tris. HC1 (pH 7.5), 6 mM KC1, 40 /xM MgCI 2 and 
25 /xM [35S]ATP~S (1400 dpm/pmol)) and incubated on ice for the 
times indicated, the phosphoenzyme was isolated by rapid filtration 
through nitrocellulose filters and measured by liquid scintillation. The 
solid lines are fits of the data to a single exponential. For the immune 
serum, the amplitude of the exponential, ai, equals 3.33+0.30 pmol 
E-(S)P, with a rate constant k i of 2.73+0.95 min -1. For the controls 
with pre-immune serum, the corresponding values are ap = 9.31 +0.16 
pmol E-(S)P and kp = 2.89+_0.2 min -1 . 
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Indeed, when the solution injected contained Fab in addi- 
tion to ATPyS, the rate of muscarinic K ÷ current activa- 
tion was decreased (99% level of confidence) from 10.9 _ 
1.0%/min (n = 10) to 3.6 _+ 0.73%/min (n = 7). Further- 
more, after agonist-independent ac ivation had reached 
steady levels, application of ACh-induced currents of com- 
parable magnitude in control and Fab-injected cells. In the 
presence of an irrelevant Fab (to B. pertussis adenylate 
cyclase toxin, also at 1.2 /xM) the rates of activation of 
IKAc, by ATPyS were 16.87 + 7.6%/min (n = 3), a value 
not significantly different from the one obtained in con- 
trols. These results demonstrate hat formation of GTPT S 
by NDPK underlies the effects of ATPyS on IKAC. 
We also monitored the effect of anti-NDPK Fab frag- 
ments on the stimulation of calcium cur rents  ( Ica)  by 
ATPyS. It was proposed [52] that ATPTS was utilized 
directly by a protein kinase (presumably the cAMP-depen- 
dent protein kinase, PKA) to stably phosphorylate L-type 
Ca 2+ channels. On the other hand, the opening of cardiac 
Ca 2+ channels is regulated by receptors via the G proteins 
G i and G~, which modulate the activity of cardiac adeny- 
late cyclase and consequently affect he phosphorylation f 
L-type Ca 2 + channels by PKA. Formation of small amounts 
of GTPTS by NDPK could thus affect ICa through a 
parallel pathway, depending on the balance between the 
basal activities of Gi and G~. The potentially dual effect of 
ATPT S has complicated considerably the interpretation f
its effects on Ica. Our results (Fig. 5B) clarify this issue, 
since stimulation of Ica by ATPyS was not affected by 
anti-NDPK Fab. The increase in Ica , expressed as the ratio 
of the ATPyS-stimulated current to the basal current in 
each cell, was the same in controls (2.33 + 0.40-fold, 
n = 9) and in the presence of Fab (2.57 _+ 0.48-fold, n = 
10). Thus, ATPyS increases Ca 2+ currents through a 
process that is not affected by antibodies to NDPK, and is 
therefore not likely to involve G protein activation by 
GTPTS formed in situ. 
4. Discussion 
NDPK has been purified from a variety of sources 
[20,22,29-33,42-44], by methods that vary widely in 
speed, yield and final specific activity. Optimization of the 
dye-affinity chromatography step is a key feature of the 
present protocol. The selection of Reactive Yellow 3 led to 
a large increase in specific activity early in the purification 
process, reducing the protein content o amounts compati- 
ble with higher resolution methods. This in turn decreased 
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Fig. 5. Effect of anti-NDPK Fab fragments on the stimulation of atrial currents by ATPyS. Shown are membrane currents recorded from two different 
atrial myocytes, plotted as a function of time. Each symbol represents he current elicited by voltage steps of 250 ms to - 5 mV, from a holding potential 
of -85  mV. Ica represents he peak inward current measured 5-10 s after depolarization to -5  mV, while I KACh was detected by an increase in the 
steady-state current recorded during the last 10 ms of the voltage step. A: Activation of muscarinic K + currents by ATPyS. The external solution 
contained 1 tzM ACh during the periods indicated by the horizontal bars. The response to muscarinic receptor stimulation, indicated by an increase in 
outward currents (upward deflection) was assessed in each cell with an extracellular application of ACh, while both the patch and the perfusion pipette 
were still filled with standard internal solution. After agonist washout, the currents returned to the basal level. Pressure (5-15 psi) was then applied to the 
reservoir containing the test solutions indicated (2 mM ATPy S, with and without 1.2 p,M Fab) at the time marked by the arrow. After the injection of 4/xl 
of test solution (4-7 min) the pressure was released. When agonist-independent activation of Irach reached a stable level, ACh was added again in order to 
estimate the maximal current in the presence of ATPyS, with and without co-injection of Fab fragments. B: Stimulation of Ica by ATPyS. Calcium 
currents were measured as described in Section 2, in K+-containing solutions. The currents measured before injection reflect he basal calcium currents. At 
the arrow, test solutions were injected into the cells. Note that when the currents in each cell are normalized using the basal currents, the magnitudes and 
time courses of stimulation of calcium currents are indistinguishable. Injection of standard internal solution did not affect lca: the ratio between the 
currents measured immediately before injection and 12-15 rain later was 1.02 + 0.10 (n = 5). 
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considerably the time necessary to obtain highly purified 
enzyme at high yields. These features are essential for the 
development of antibodies with the selectivity necessary 
for use in intact cells. 
Frog NDPK proved to be a very effective immunogen 
in rabbits, inducing the production of specific immuno- 
globulins, some with inhibitory properties, in all the ani- 
mals injected. The less than complete block of frog NDPK 
was not due to a subpopuhttion f the enzyme that did not 
react with antibody, since NDPK was immunoprecipitated 
quantitatively (not shown) at a serum dilution (1:300) that 
left 20% of the enzyme activity untouched (Fig. 3A). 
Similar observations were previously made with antibodies 
to Dictyostelium NDPK, which do not fully block enzyme 
activity [22]. Fig. 4 shows; that the rate constant of auto- 
phosphorylation is not affected by the antibodies to NDPK, 
suggesting that in the presence of immune serum most 
catalytic sites are fully blocked by the antibodies, while the 
remaining enzyme units are entirely free of inhibition, and 
react with ATPy S at the normal rate. Taken together, these 
results indicate that incomplete inhibition arises because 
binding of neutralizing antibodies is hindered by null 
immunoglobulins, which interact with neighboring epi- 
topes but do not affect NDPK function. 
The observation that antibodies produced against frog 
NDPK do not inhibit the activity of human NDPK, al- 
though they recognize it in immunoblots after elec- 
trophoresis under denaturing conditions, suggests that the 
amphibian and mammalian enzymes differ in the structure 
of the epitope(s) involved in the blocking effect. 
Various characteristics of the antibodies elicited by frog 
NDPK suggest that they may be useful as specific tools to 
examine the physiological relevance of catalytic activity to 
function. The most important is that they recognize and 
inactivate most of the enzyme at very low concentrations, 
and do so rapidly; features that are of particular impor- 
tance to assess NDPK function in intact cells. The results 
obtained by injection of Fab fragments in atrial myocytes 
exemplify the use of these antibodies to identify in vivo 
processes that involve NDPK. Using the patch clamp 
technique, we obtained irect proof that the mechanisms 
by which ATP'xS affects two ion channels in atrial cells 
are completely unrelated. In the case of muscarinic K + 
channels, the data confirm the hypothesis that activation of 
IKAch by ATPyS is a result of GTP?S formation by atrial 
NDPK and the consequent activation of G k [46]. In con- 
trast, the lack of effect of the Fab fragments on the 
stimulation of calcium channels by ATPy S clearly support 
the proposal that this process reflects the direct transfer of 
thiophosphate from the ATP analog into the channel pro- 
tein by a protein kinase [:52], being independent of NDPK 
activity. Taken together, the data demonstrate hat anti- 
NDPK antibodies inhibit the enzyme in intact cells, lead- 
ing us to anticipate that these antibodies will help to 
validate and extend the liLst of cellular processes in which 
NDPK plays an essential role. 
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